David A. Socks

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Molly Henderson, Attorney-in-Fact for David A. Socks
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David A. Socks

Form 4 holding CFO & Chief Business Officer

HilleVax, Inc.

Security class
Common Stock
Shares / value
769,055
Estimated value
$11,920,353
Report date
28 Apr 2022
Price
$15.50
Ownership
Indirect
Form 4 holding Director

Phathom Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
1,211,346
Estimated value
$11,035,362
Report date
23 May 2024
Price
$9.11
Ownership
David A. Socks Family Trust
Form 4 holding Director

Phathom Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
17,500
Estimated value
Report date
23 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by David A. Socks

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .